| Mark H Camel, MD | |
|
6 Greenwich Office Park, Greenwich, CT 06831-5151 | |
| (203) 869-1145 | |
| (203) 618-1721 |
| Full Name | Mark H Camel |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 43 Years |
| Location | 6 Greenwich Office Park, Greenwich, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295706737 | NPI | - | NPPES |
| 140005669 | Other | CT | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 028041 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greenwich Hospital Association - | Greenwich, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic And Neurosurgery Specialists, Pllc | 5294628947 | 208 |
| Orthopaedic And Neurosurgery Specialists, Pllc | 5294628947 | 208 |
| Rehabilitation Associates Inc | 8022905322 | 297 |
News Archive
Bristol researchers have identified a heart protection mechanism in mice that surgeons and cardiologists may be able to exploit to improve treatments for patients in future.
Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.
Researchers at the University of Sheffield have found that there are substantially increased death rates from alcohol-related diseases in socioeconomically deprived areas of England and Wales.
Woodland Hills insurer Health Net Inc. said third-quarter net income plunged 71%, but its shares rose as the company resolved a dispute with California officials over reimbursement for government health programs. Health Net disappointed investors in August when it slashed its full-year profit outlook and reported higher-than-expected medical costs. On Monday, Chief Executive Jay Gellert ... cited a wide-ranging agreement with California healthcare officials as a major step forward.
A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as glioblastoma.
› Verified 1 days ago
| Entity Name | Greenwich Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609846088 PECOS PAC ID: 3678476710 Enrollment ID: O20040128000288 |
News Archive
Bristol researchers have identified a heart protection mechanism in mice that surgeons and cardiologists may be able to exploit to improve treatments for patients in future.
Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.
Researchers at the University of Sheffield have found that there are substantially increased death rates from alcohol-related diseases in socioeconomically deprived areas of England and Wales.
Woodland Hills insurer Health Net Inc. said third-quarter net income plunged 71%, but its shares rose as the company resolved a dispute with California officials over reimbursement for government health programs. Health Net disappointed investors in August when it slashed its full-year profit outlook and reported higher-than-expected medical costs. On Monday, Chief Executive Jay Gellert ... cited a wide-ranging agreement with California healthcare officials as a major step forward.
A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as glioblastoma.
› Verified 1 days ago
| Entity Name | Orthopaedic & Neurosurgery Specialists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033318720 PECOS PAC ID: 5294628947 Enrollment ID: O20040205000859 |
News Archive
Bristol researchers have identified a heart protection mechanism in mice that surgeons and cardiologists may be able to exploit to improve treatments for patients in future.
Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.
Researchers at the University of Sheffield have found that there are substantially increased death rates from alcohol-related diseases in socioeconomically deprived areas of England and Wales.
Woodland Hills insurer Health Net Inc. said third-quarter net income plunged 71%, but its shares rose as the company resolved a dispute with California officials over reimbursement for government health programs. Health Net disappointed investors in August when it slashed its full-year profit outlook and reported higher-than-expected medical costs. On Monday, Chief Executive Jay Gellert ... cited a wide-ranging agreement with California healthcare officials as a major step forward.
A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as glioblastoma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark H Camel, MD 6 Greenwich Office Park, Greenwich, CT 06831-5151 Ph: (203) 869-1145 | Mark H Camel, MD 6 Greenwich Office Park, Greenwich, CT 06831-5151 Ph: (203) 869-1145 |
News Archive
Bristol researchers have identified a heart protection mechanism in mice that surgeons and cardiologists may be able to exploit to improve treatments for patients in future.
Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.
Researchers at the University of Sheffield have found that there are substantially increased death rates from alcohol-related diseases in socioeconomically deprived areas of England and Wales.
Woodland Hills insurer Health Net Inc. said third-quarter net income plunged 71%, but its shares rose as the company resolved a dispute with California officials over reimbursement for government health programs. Health Net disappointed investors in August when it slashed its full-year profit outlook and reported higher-than-expected medical costs. On Monday, Chief Executive Jay Gellert ... cited a wide-ranging agreement with California healthcare officials as a major step forward.
A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as glioblastoma.
› Verified 1 days ago
Andrea F Douglas, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 25 Valley Dr, Greenwich, CT 06831 Phone: 203-661-3333 Fax: 203-661-5610 | |
Paul Jon Apostolides, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 | |
John G Strugar, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 15 Valley Dr, Greenwich, CT 06831 Phone: 203-785-2807 Fax: 203-863-4496 | |
Zion Zibly, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 15 Valley Dr Ste 201, Greenwich, CT 06831 Phone: 203-737-2096 | |
Scott L Simon, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 | |
Amory J Fiore, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 |